S-1 S-1 EX-FILING FEES 0001541157 Akari Therapeutics Plc N/A N/A 0001541157 2026-05-08 2026-05-08 0001541157 1 2026-05-08 2026-05-08 0001541157 2 2026-05-08 2026-05-08 0001541157 3 2026-05-08 2026-05-08 0001541157 4 2026-05-08 2026-05-08 0001541157 5 2026-05-08 2026-05-08 0001541157 6 2026-05-08 2026-05-08 0001541157 7 2026-05-08 2026-05-08 0001541157 8 2026-05-08 2026-05-08 0001541157 9 2026-05-08 2026-05-08 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-1

Akari Therapeutics Plc

Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Equity Ordinary shares, nominal value $0.000000005 per share ("ordinary shares"), as represented by American Depositary Shares ("ADSs") 457(o) $ 7,500,000.00 0.0001381 $ 1,035.75
Fees to be Paid 2 Other Pre-funded warrants to purchase ordinary shares, as represented by ADSs Other $ 0.00 0.0001381 $ 0.00
Fees to be Paid 3 Equity Ordinary shares, as represented by ADSs, issuable upon exercise of the pre-funded warrants 457(o) $ 0.00 0.0001381 $ 0.00
Fees to be Paid 4 Other Series H common warrants to purchase ordinary shares, as represented by ADSs Other $ 0.00 0.0001381 $ 0.00
Fees to be Paid Equity Ordinary shares, as represented by ADSs, issuable upon exercise of the Series H common warrants 457(o) $ 7,500,000.00 0.0001381 $ 1,035.75
Fees to be Paid 5 Other Series I common warrants to purchase ordinary shares, as represented by ADSs Other $ 0.00 0.0001381 $ 0.00
Fees to be Paid Equity Ordinary shares, as represented by ADSs, issuable upon exercise of the Series I common warrants 457(o) $ 7,500,000.00 0.0001381 $ 1,035.75
Fees to be Paid 6 Other Placement agent warrants to purchase ordinary shares, as represented by ADSs Other $ 0.00 0.0001381 $ 0.00
Fees to be Paid 7 Equity Ordinary shares, as represented by ADSs, issuable upon exercise of the placement agent warrants 457(o) $ 281,250.00 0.0001381 $ 38.84
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 22,781,250.00

$ 3,146.09

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 3,146.09

Offering Note

1

Security Class Title - Amount Registered: Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the ordinary shares as represented by ADSs registered hereby also include an indeterminate number of additional ordinary shares as represented by ADSs as may from time to time become issuable by reason of stock splits, stock dividends, recapitalizations or other similar transactions. Estimated solely for purposes of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act.

2

The registrant may issue pre-funded warrants to purchase ordinary shares as represented by ADSs in the offering. The purchase price of each pre-funded warrant will equal the price per share at which the ADSs are being sold to the public in this offering, minus $0.001, which constitutes the pre-funded portion of the exercise price, and the remaining unpaid exercise price of the pre-funded warrant will equal $0.001 per ADS (subject to adjustment as provided for therein). The proposed maximum aggregate offering price of the ordinary shares as represented by ADSs will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any ordinary shares as represented by ADSs issued in the offering. Accordingly, the proposed maximum aggregate offering price of the ordinary shares as represented by ADSs and pre-funded warrants (including the ordinary shares as represented by ADSs issuable upon exercise of the pre-funded warrants), if any, is $7,500,000. No separate fee is required pursuant to Rule 457(g) of the Securities Act.

3

The registrant may issue pre-funded warrants to purchase ordinary shares as represented by ADSs in the offering. The purchase price of each pre-funded warrant will equal the price per share at which the ADSs are being sold to the public in this offering, minus $0.001, which constitutes the pre-funded portion of the exercise price, and the remaining unpaid exercise price of the pre-funded warrant will equal $0.001 per ADS (subject to adjustment as provided for therein). The proposed maximum aggregate offering price of the ordinary shares as represented by ADSs will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any ordinary shares issued in the offering. Accordingly, the proposed maximum aggregate offering price of the ordinary shares as represented by ADSs and pre-funded warrants (including the ordinary shares as represented by ADSs issuable upon exercise of the pre-funded warrants), if any, is $7,500,000.

4

No separate fee is required pursuant to Rule 457(g) of the Securities Act.

5

No separate fee is required pursuant to Rule 457(g) of the Securities Act.

6

No separate fee is required pursuant to Rule 457(g) of the Securities Act.

7

As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act, the proposed maximum aggregate offering price of the placement agent's warrants is $281,250, which is equal to 3.0% of the aggregate value of the ADSs to be sold in the offering at an exercise price equal to 125% of the public offering price per share.

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rules 457(b) and 0-11(a)(2)
Fee Offset Claims
Fee Offset Sources
Rule 457(p)
Fee Offset Claims
Fee Offset Sources
Table 3: Combined Prospectuses ☑Not Applicable

Security Type

Security Class Title

Amount of Securities Previously Registered

Maximum Aggregate Offering Price of Securities Previously Registered

Form Type

File Number

Initial Effective Date